BRICKELL BIOTECH INC (BBI) Stock Analyst Earnings Estimates
NASDAQ:BBI - Nasdaq - US10802T2042 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.92M 388.89% | 1.82M -77.02% | 404K -77.80% | 6.215M 1,438.25% | 7.188M 15.66% | 6.06M -15.69% | 5.999M -1.00% | 5.998M -0.01% | |
| EBITDA YoY % growth | -19.64M -8.45% | -20.97M -6.77% | -40.222M -91.81% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -19.67M -7.72% | -20.98M -6.66% | -40.244M -91.82% | -21.446M 46.71% | -22.837M -6.49% | -26.159M -14.54% | -23.176M 11.40% | -20.739M 10.52% | |
| Operating Margin | -248.36% | -1,152.75% | -9,961.39% | -345.09% | -317.72% | -431.67% | -386.33% | -345.75% | |
| EPS YoY % growth | N/A | N/A | -23.85 26.09% | -7.00 70.65% | -6.85 2.16% | -6.85 | -6.85 -0.08% | -6.93 -1.08% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.87 74.05% | -1.11 58.85% | -1.50 58.20% | -1.55 -15,353.00% | -0.40 78.38% | -1.45 -30.91% | -1.68 -11.41% | -1.88 -21.57% | -1.07 -165.00% | -2.21 -52.08% |
| Revenue Q2Q % growth | 208.737K 58.13% | 1.557M 1,397.20% | 318.15K 245.82% | 505K -84.05% | 4.545M 2,077.38% | 626.2K -59.78% | 505K 58.73% | 505K | 4.545M | 505K -19.35% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.741M 57.02% | -4.719M 25.15% | -8.757M 6.91% | 4.328M 214.20% | -10.666M -85.77% | -10.812M -129.11% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.01 99.86% | -1.45 | 1.44 | 99.31% |
| Q1 2022 Q2Q % growth | -3.60 46.67% | -2.61 | -0.99 | -37.75% |
| Q4 2021 Q2Q % growth | -2.70 60.00% | -3.86 | 1.16 | 30.11% |
| Q3 2021 Q2Q % growth | -7.20 -6.67% | -5.68 | -1.52 | -26.73% |
| Q2 2021 Q2Q % growth | -7.20 | -5.68 | -1.52 | -26.73% |
| Q1 2021 Q2Q % growth | -6.75 | -5.23 | -1.52 | -29.14% |
| Q4 2020 Q2Q % growth | -6.75 -393.68% | -4.09 | -2.66 | -65.02% |
| Q3 2020 Q2Q % growth | -6.75 | -8.41 | 1.66 | 19.72% |
| Q2 2019 Q2Q % growth | -0.77 | -0.78 | 0.01 | 0.99% |
| Q1 2019 Q2Q % growth | -1.47 | -1.27 | -0.20 | -15.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 1,997.14% | 3.167M | % | |
| Q1 2022 Q2Q % growth | 92K 360.00% | 145.188K | -53.188K | -36.63% |
| Q4 2021 Q2Q % growth | 104K 246.67% | 156.298K | -52.298K | -33.46% |
| Q3 2021 Q2Q % growth | 132K -5.71% | 151.5K | -19.5K | -12.87% |
| Q2 2021 Q2Q % growth | 151K -75.25% | 50.5K | 100.5K | 199.01% |
| Q1 2021 Q2Q % growth | 20K -98.10% | 50.5K | -30.5K | -60.40% |
| Q4 2020 Q2Q % growth | 30K -95.52% | 505K | -475K | -94.06% |
| Q3 2020 Q2Q % growth | 140K -88.14% | 505K | -365K | -72.28% |
| Q2 2020 Q2Q % growth | 610K -76.26% | % | ||
| Q1 2020 Q2Q % growth | 1.05M -69.91% | % | ||
| Q2 2019 Q2Q % growth | 2.57M | 5.05K | 2.565M | 50,791.09% |
| Q1 2019 Q2Q % growth | 3.49M | 5.05K | 3.485M | 69,008.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |